BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 10701740)

  • 1. Recovery of sperm production following radiation therapy for Hodgkin's disease after induction chemotherapy with mitoxantrone, vincristine, vinblastine, and prednisone (NOVP).
    Dubey P; Wilson G; Mathur KK; Hagemeister FB; Fuller LM; Ha CS; Cox JD; Meistrich ML
    Int J Radiat Oncol Biol Phys; 2000 Feb; 46(3):609-17. PubMed ID: 10701740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid recovery of spermatogenesis after mitoxantrone, vincristine, vinblastine, and prednisone chemotherapy for Hodgkin's disease.
    Meistrich ML; Wilson G; Mathur K; Fuller LM; Rodriguez MA; McLaughlin P; Romaguera JE; Cabanillas FF; Ha CS; Lipshultz LI; Hagemeister FB
    J Clin Oncol; 1997 Dec; 15(12):3488-95. PubMed ID: 9396402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NOVP: a novel chemotherapeutic regimen with minimal toxicity for treatment of Hodgkin's disease.
    Hagemeister FB; Cabanillas F; Velásquez WS; Meistrich ML; Liang JC; McLaughlin P; Redman JR; Romaguera JE; Rodríguez MA; Swan F
    Semin Oncol; 1990 Dec; 17(6 Suppl 10):34-8; discussion 38-40. PubMed ID: 2259922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spermatogenesis in Hodgkin's lymphoma patients: a retrospective study of semen quality before and after different chemotherapy regimens.
    Paoli D; Rizzo F; Fiore G; Pallotti F; Pulsoni A; Annechini G; Lombardo F; Lenzi A; Gandini L
    Hum Reprod; 2016 Feb; 31(2):263-72. PubMed ID: 26705149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of stage I and II Hodgkin's disease with NOVP (mitoxantrone, vincristine, vinblastine, prednisone) and radiotherapy.
    Tormo M; Terol MJ; Marugán I; Solano C; Benet I; Garcia-Conde J
    Leuk Lymphoma; 1999 Jun; 34(1-2):137-42. PubMed ID: 10350341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recovery of spermatogenesis after treatment for Hodgkin's disease: limiting dose of MOPP chemotherapy.
    da Cunha MF; Meistrich ML; Fuller LM; Cundiff JH; Hagemeister FB; Velasquez WS; McLaughlin P; Riggs SA; Cabanillas FF; Salvador PG
    J Clin Oncol; 1984 Jun; 2(6):571-7. PubMed ID: 6547167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NOVP chemotherapy for Hodgkin's disease transiently induces sperm aneuploidies associated with the major clinical aneuploidy syndromes involving chromosomes X, Y, 18, and 21.
    Frias S; Van Hummelen P; Meistrich ML; Lowe XR; Hagemeister FB; Shelby MD; Bishop JB; Wyrobek AJ
    Cancer Res; 2003 Jan; 63(1):44-51. PubMed ID: 12517776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NOVP and radiotherapy for early-staged Hodgkin's disease: an interim analysis.
    Hagemeister FB; Fuller L; McLaughlin P; Rodriguez M; Romaguera J; Swan F; Cabanillas F
    Ann Oncol; 1992 Sep; 3 Suppl 4():87-90. PubMed ID: 1450086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hodgkin's disease with a mediastinal mass greater than 10 cm: results of four different treatment approaches.
    Preti A; Hagemeister FB; McLaughlin P; Swan F; Rodriguez A; Besa P; Cox JD; Allen PK; Cabanillas F
    Ann Oncol; 1994; 5 Suppl 2():97-100. PubMed ID: 7515653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new chemotherapy regimen for treatment of Hodgkin's disease associated with minimal genotoxicity.
    Liang JC; Bailey NM; Gabriel GJ; Kattan MW; Wang RY; Hagemeister FB; Cabanillas FF; Fuller LM
    Leuk Lymphoma; 1993 Apr; 9(6):503-8. PubMed ID: 7687918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. European Organization for Research and Treatment of Cancer and Groupe d'Etude des Lymphomes de l'Adulte very favorable and favorable, lymphocyte-predominant Hodgkin disease.
    Wilder RB; Schlembach PJ; Jones D; Chronowski GM; Ha CS; Younes A; Hagemeister FB; Barista I; Cabanillas F; Cox JD
    Cancer; 2002 Mar; 94(6):1731-8. PubMed ID: 11920535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are alkylating agents a necessary component in the therapy of Hodgkin's disease.
    Hagemeister FB
    Leuk Lymphoma; 1993; 10 Suppl():91-7. PubMed ID: 7683230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The gallium scan predicts relapse in patients with Hodgkin's disease treated with combined modality therapy.
    Hagemeister FB; Purugganan R; Podoloff DA; Hess M; Rodriguez MA; McLaughlin P; Swan F; Romaguera JE; Cabanillas F
    Ann Oncol; 1994; 5 Suppl 2():59-63. PubMed ID: 8204521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brief chemotherapy, Stanford V, and adjuvant radiotherapy for bulky or advanced-stage Hodgkin's disease: a preliminary report.
    Bartlett NL; Rosenberg SA; Hoppe RT; Hancock SL; Horning SJ
    J Clin Oncol; 1995 May; 13(5):1080-8. PubMed ID: 7537796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of early stages of Hodgkin's disease with novantrone, vincristine, vinblastine, prednisone, and radiotherapy.
    Hagemeister FB; Purugganan R; Fuller L; McLaughlin P; Swan F; Romaguera J; Rodriguez M; Cabanillas F
    Semin Hematol; 1994 Apr; 31(2 Suppl 3):36-43. PubMed ID: 8073308
    [No Abstract]   [Full Text] [Related]  

  • 16. Meiotic susceptibility for induction of sperm with chromosomal aberrations in patients receiving combination chemotherapy for Hodgkin lymphoma.
    Frias S; Van Hummelen P; Meistrich ML; Wyrobek AJ
    PLoS One; 2020; 15(12):e0242218. PubMed ID: 33370316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alternating MOPP and ABVD chemotherapy plus mantle-field radiation therapy in patients with massive mediastinal Hodgkin's disease.
    Longo DL; Glatstein E; Duffey PL; Young RC; Ihde DC; Bastian AW; Wilson WH; Wittes RE; Jaffe ES; Hubbard SM; DeVita VT
    J Clin Oncol; 1997 Nov; 15(11):3338-46. PubMed ID: 9363863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Male reproductive potential after MOPP therapy for Hodgkin's disease: a long-term survey.
    Marmor D; Duyck F
    Andrologia; 1995; 27(2):99-106. PubMed ID: 7598233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term reduction in sperm count after chemotherapy with and without radiation therapy for non-Hodgkin's lymphomas.
    Pryzant RM; Meistrich ML; Wilson G; Brown B; McLaughlin P
    J Clin Oncol; 1993 Feb; 11(2):239-47. PubMed ID: 8426200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of lymphoma treatments on spermatogenesis and sperm deoxyribonucleic acid: a multicenter prospective study from the CECOS network.
    Bujan L; Walschaerts M; Brugnon F; Daudin M; Berthaut I; Auger J; Saias J; Szerman E; Moinard N; Rives N; Hennebicq S
    Fertil Steril; 2014 Sep; 102(3):667-674.e3. PubMed ID: 25044088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.